Vermont Removes Nexium From Medicaid Preferred Drug List To Reduce Costs

Main Category: Medicare / Medicaid / SCHIP
Article Date: 23 Jun 2006 - 20:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Vermont on Monday began requiring Medicaid beneficiaries to obtain prior authorization from their physicians before obtaining prescriptions for the acid reflux treatment Nexium, the Burlington Free Press reports. According to the Free Press, the move illustrates the "state's strategy to curb the growth in the cost of prescription drugs in the Medicaid program," which faces a projected budget deficit of $42 million for the fiscal year beginning July 1, 2007. In recent years, prescription drug spending has outpaced spending for nursing home care and inpatient hospital care, becoming the No. 1 expense under the Medicaid program. To help control costs, the state in 2002 established the Drug Utilization Review Board to create and monitor a Medicaid preferred drug list. In order for a beneficiary to receive coverage for a medication that is not on the list, a physician must demonstrate to the state prescription drug manager that there is no other acceptable treatment for the beneficiary's condition. James Gray, chair of the Drug Utilization Review Board, said, "If we aren't careful about how we use our drugs, we are going to run out of money," adding, "Better to choose from drugs that are much less costly." The state in 2005 spent $14.6 million gastric acid reducers, such as Nexium. Gray said the change "is not only to control costs, but to choose the medication that is most appropriate for the problem that you are dealing with." Ann Rugg, deputy director of the Office of Vermont Health Access, said the issue of high prescription drug cost is "not unique to Vermont" and "not unique to Medicaid." She added that "clinically appropriate alternatives" to Nexium are "available at [a] lesser cost." Gastric acid reducers, along with medications for high cholesterol and mental health conditions, are the top prescription drug expenses for both Medicaid and Blue Cross Blue Shield of Vermont, the state's largest private insurer (Remsen, Burlington Free Press, 6/19).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

View drug information on Nexium.


Article adapted by Medical News Today from original press release.
Visit our medicare / medicaid / schip section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Barbara Martin. "Vermont Removes Nexium From Medicaid Preferred Drug List To Reduce Costs." Medical News Today. MediLexicon, Intl., 23 Jun. 2006. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/45690.php>

APA
Barbara Martin. (2006, June 23). "Vermont Removes Nexium From Medicaid Preferred Drug List To Reduce Costs." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/45690.php.

Please note: If no author information is provided, the source is cited instead.


Medicare / Medicaid / SCHIP

What is Medicare / Medicaid?

Medicaid and Medicare are two governmental programs that provide medical and health-related services to specific groups of people in the United States. Although the two programs are very different, they are both managed by the Centers for Medicare and... Read more...

Most Popular Articles



Follow Our Medicare News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Medicare / Medicaid / SCHIP Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »